Exhibit 9 KOREAN REXAHN INVESTORS VOTING TRUST AGREEMENT THIS VOTING TRUST AGREEMENT (this "Agreement") is effective for all purposes and in all respects as of the ____ day of July, 2003, by and among (i) Chang-Ho Ahn ("Ahn") and Young-Soon Park...Voting Trust Agreement • March 31st, 2006 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
License AgreementLicense Agreement • March 31st, 2006 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This License Agreement (“Agreement”) is made and entered into effective as of February 8, 2005 (the “Effective Date”), by and between Revaax Pharmaceuticals LLC, an Indiana corporation (“Licensor”), and Rexahn Corporation, a Delaware corporation (“Licensee”). Licensor and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
RESEARCH COLLABORATION AGREEMENT ON RX-0201 CLINICAL DEVELOPMENTResearch Collaboration Agreement • March 31st, 2006 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This RESEARCH COLLABORATION AGREEMENT ON RX-0201 CLINICAL DEVELOPMENT (the "Agreement") is entered into between Rexahn Corporation, a company based in the United States, carrying on business at 9700 Great Seneca Highway, Rockville MD 20850 USA ("REXAHN ") and REXGENE Biotech Co., Ltd., located at 1330-13 Seocho-Dong, Seocho-Gu, Seoul, Korea ("REXGENE"). REXAHN and REXGENE are collectively referred to as "Parties" and individually referred to as "Party" in this Agreement.
